---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029787"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:19:10.471173+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# TRxADE HEALTH completes merger with Scienture; issues Series X preferred convertible to common

## Summary
- Closed merger with Scienture Inc. on July 25; Scienture holders get 291,555 common shares (19.99% of pre-deal float) and 6,826,713 Series X non-voting convertible preferred shares.
- Company to rename to Scienture Holdings, Inc. after stockholder written consent becomes effective (20 days after information statement mailed).
- Board expands to 7; Shankar Hariharan and Narasimhan Mani appointed as directors.
- CEO and CFO remain; lock-up agreements prohibit transfer of shares for 180 days post preferred stock conversion.
- Consulting agreements with Suren Ajjarapu (702,086 common shares) and Prashant Patel (614,325 common shares) effective upon termination of employment.

## SEC filing metadata
- accession: 0001493152-24-029787
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 5.03, 2.01, 3.02, 3.03, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029787
- JSON: https://secwatch.observer/filing/0001493152-24-029787.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029787.txt

## Key facts
- Executive change
  Shankar Hariharan was appointed as Director at Scienture Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: on July 25, 2024, the Company’s Board appointed Shankar Hariharan and Narasimhan Mani to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm
- Executive change
  Narasimhan Mani was appointed as Director at Scienture Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: on July 25, 2024, the Company’s Board appointed Shankar Hariharan and Narasimhan Mani to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm
- M&A Transactions
  Scienture Holdings, Inc. completed an acquisition involving Scienture, Inc. (closed 2024-07-25).
  - Action: acquisition
  - Counterparty: Scienture, Inc.
  - Closing: 2024-07-25
  source text: The parties consummated the Mergers on July 25, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.